AVITA Medical to Present at the Cantor Global Healthcare Conference
21 sept. 2023 16h30 HE
|
AVITA Medical
VALENCIA, Calif., Sept. 21, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class...
AVITA Medical to Participate in Upcoming Investor Conferences
06 sept. 2023 18h45 HE
|
AVITA Medical
VALENCIA, Calif., Sept. 06, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class...
AVITA Medical to Host Investor Webinar Briefing
14 août 2023 08h00 HE
|
AVITA Medical
VALENCIA, Calif., Aug. 14, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class...
AVITA Medical Reports Second Quarter Financial Results
10 août 2023 16h01 HE
|
AVITA Medical
VALENCIA, Calif., Aug. 10, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a regenerative medicine company leading the development and commercialization of...
AVITA Medical to Announce Second Quarter 2023 Financial Results
20 juil. 2023 16h05 HE
|
AVITA Medical
VALENCIA, Calif., July 20, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class...
AVITA Medical Submits FDA PMA Supplement for RECELL GO
29 juin 2023 18h21 HE
|
AVITA Medical
VALENCIA, Calif., June 29, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class...
AVITA Medical Rejoins the Russell 3000 Index
26 juin 2023 08h00 HE
|
AVITA Medical
VALENCIA, Calif., and MELBOURNE, Australia, June 26, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and...
AVITA Medical Announces FDA Approval of RECELL for Skin Repigmentation in Vitiligo Patients
16 juin 2023 14h47 HE
|
AVITA Medical
VALENCIA, Calif. and MELBOURNE, Australia, June 16, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and...
AVITA Medical Announces Appointment of David O’Toole as Chief Financial Officer
15 juin 2023 16h05 HE
|
AVITA Medical
VALENCIA, Calif. and MELBOURNE, Australia, June 15, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and...
AVITA Medical Announces FDA Approval of RECELL for Treatment of Full-Thickness Skin Defects
07 juin 2023 20h00 HE
|
AVITA Medical
VALENCIA, Calif. and MELBOURNE, Australia, June 07, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and...